Lataa...
Autologous Lymphapheresis for the Production of Chimeric Antigen Receptor (CAR) T Cells
BACKGROUND: Chimeric antigen receptor (CAR) T cells are a promising new immunotherapy. The first step in manufacturing is to collect autologous CD3+ lymphocytes by apheresis. Patients, however, are often leukopenic or have other disease-related complications. We evaluated the feasibility of collecti...
Tallennettuna:
| Julkaisussa: | Transfusion |
|---|---|
| Päätekijät: | , , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2017
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5398918/ https://ncbi.nlm.nih.gov/pubmed/28236305 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/trf.14003 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|